SOUTH SAN FRANCISCO, CA--(Marketwired - March 04, 2015) - diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that it will report fourth quarter and full year 2014 financial results on Wednesday, March 11, 2015 after market close, and will host a conference call to discuss financial results and provide a business update at 4:30 p.m. ET (1:30 p.m. PT) to discuss results and provide a business update.
To access the webcast, visit the Company's website at www.Diadexus.com/webcast. To access the conference call, dial 1 (855) 666-6874 for domestic callers and (262) 912-6259 for international callers. The reservation number for both is 86573797. A replay of the webcast will be available shortly following the live webcast for a period of four weeks.
About diaDexus, Inc.
diaDexus, Inc., based in South San Francisco, California, develops and commercializes proprietary cardiovascular diagnostic products addressing unmet needs in cardiovascular disease. The Company's two diagnostic products are the only FDA-cleared Lp-PLA2 blood tests to uncover the hidden risk of cardiovascular disease. The PLAC® Test ELISA Kit is to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk for both coronary heart disease and ischemic stroke associated with atherosclerosis, the #1 and #3 causes of death, respectively, in the United States. The PLAC® Test for Lp-PLA2 Activity is to be used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of coronary heart disease in patients with no prior history of cardiovascular events, which represents approximately 75% of coronary heart disease patients. The Company also has heart failure biomarkers for development. For more information, please visit the Company's website at www.diaDexus.com.
Help employers find you! Check out all the jobs and post your resume.
